Literature DB >> 30857981

Harmonized outcome measures for use in asthma patient registries and clinical practice.

Richard E Gliklich1, Mario Castro2, Michelle B Leavy3, Valerie G Press4, Amisha Barochia5, Christopher L Carroll6, Julie Harris7, Sarah S Rittner8, Robert Freishtat9, Reynold A Panettieri10, Giselle S Mosnaim11.   

Abstract

BACKGROUND: Asthma, a common chronic airway disorder, affects an estimated 25 million persons in the United States and 330 million persons worldwide. Although many asthma patient registries exist, the ability to link and compare data across registries is hindered by a lack of harmonization in the outcome measures collected by each registry.
OBJECTIVES: The purpose of this project was to develop a minimum set of patient- and provider-relevant standardized outcome measures that could be collected in asthma patient registries and clinical practice.
METHODS: Asthma registries were identified through multiple sources and invited to join the workgroup and submit outcome measures. Additional measures were identified through literature searches and reviews of quality measures and consensus statements. Outcome measures were categorized by using the Agency for Healthcare Research and Quality's supported Outcome Measures Framework. A minimum set of broadly relevant measures was identified. Measure definitions were harmonized through in-person and virtual meetings.
RESULTS: Forty-six outcome measures, including those identified from 13 registries, were curated and harmonized into a minimum set of 21 measures in the Outcome Measures Framework categories of survival, clinical response, events of interest, patient-reported outcomes, resource utilization, and experience of care. The harmonized definitions build on existing consensus statements and are appropriate for adult and pediatric patients.
CONCLUSIONS: The harmonized measures represent a minimum set of outcomes that are relevant in asthma research and clinical practice. Routine and consistent collection of these measures in registries and other systems would support creation of a national research infrastructure to efficiently address new questions and improve patient management and outcomes.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Asthma; common data element; data standard; harmonization; outcome measure; patient outcome; patient registry

Mesh:

Year:  2019        PMID: 30857981     DOI: 10.1016/j.jaci.2019.02.025

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

Review 2.  What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions.

Authors:  Anna Volerman; Delesha Carpenter; Valerie Press
Journal:  Expert Rev Respir Med       Date:  2020-04-28       Impact factor: 3.772

3.  Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice.

Authors:  Martin J Edelman; Daniel P Raymond; Dwight H Owen; Michelle B Leavy; Kari Chansky; Sriram Yennu; Felix G Fernandez; Carolyn J Presley; Tithi Biswas; Gwendolyn P Quinn; Matthew B Schabath; Seth Sheffler-Collins; Laura Chu; Richard E Gliklich
Journal:  J Natl Compr Canc Netw       Date:  2021-08-13       Impact factor: 12.693

4.  A Comparison of Health Care Expenditures for Medicaid-Insured Children with Autism Spectrum Disorder and Asthma in an Expanding Accountable Care Organization.

Authors:  Lee A Robinson; Michelle Menezes; Brian Mullin; Benjamin Lê Cook
Journal:  J Autism Dev Disord       Date:  2020-03

5.  Machine learning-driven identification of early-life air toxic combinations associated with childhood asthma outcomes.

Authors:  Yan-Chak Li; Hsiao-Hsien Leon Hsu; Yoojin Chun; Po-Hsiang Chiu; Zoe Arditi; Luz Claudio; Gaurav Pandey; Supinda Bunyavanich
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 19.456

6.  Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma.

Authors:  Adriana L da Silva; Gisele P de Oliveira; Namho Kim; Fernanda F Cruz; Jamil Z Kitoko; Natalia G Blanco; Sabrina V Martini; Justin Hanes; Patricia R M Rocco; Jung Soo Suk; Marcelo M Morales
Journal:  Sci Adv       Date:  2020-06-10       Impact factor: 14.136

7.  Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders.

Authors:  Anthony L Vaccarino; Derek Beaton; Sandra E Black; Pierre Blier; Farnak Farzan; Elizabeth Finger; Jane A Foster; Morris Freedman; Benicio N Frey; Susan Gilbert Evans; Keith Ho; Mojib Javadi; Sidney H Kennedy; Raymond W Lam; Anthony E Lang; Bianca Lasalandra; Sara Latour; Mario Masellis; Roumen V Milev; Daniel J Müller; Douglas P Munoz; Sagar V Parikh; Franca Placenza; Susan Rotzinger; Claudio N Soares; Alana Sparks; Stephen C Strother; Richard H Swartz; Brian Tan; Maria Carmela Tartaglia; Valerie H Taylor; Elizabeth Theriault; Gustavo Turecki; Rudolf Uher; Lorne Zinman; Kenneth R Evans
Journal:  Front Psychiatry       Date:  2022-02-07       Impact factor: 4.157

Review 8.  The asthma evidence base: a call for core outcomes in interventional trials.

Authors:  Vickram Tejwani; Hsing-Yuan Chang; Annie P Tran; Rachael M Moloney; Sumita B Khatri
Journal:  J Asthma       Date:  2020-04-03

Review 9.  Defining pediatric asthma: phenotypes to endotypes and beyond.

Authors:  Laura A Conrad; Michael D Cabana; Deepa Rastogi
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.